Institute for Systems Biology

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Institute for Systems Biology sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Institute for Systems Biology: 1 sponsored US clinical trial, 1 recruiting.

Institute for Systems Biology sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Metabolism, with 1 trials.

Mid-pack sponsor footprint

Institute for Systems Biology is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

Therapeutic Areas

What is open in the Institute for Systems Biology pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Metabolism (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Institute for Systems Biology: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Institute for Systems Biology sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Institute for Systems Biology1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Institute for Systems Biology sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Institute for Systems Biology sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this Institute for Systems Biology page

1 registered trials is a research-attention snapshot, not an endorsement of Institute for Systems Biology or any single study.

  • 1 of Institute for Systems Biology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Metabolism is the condition Institute for Systems Biology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Metabolism trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Institute for Systems Biology pipeline card: 1 registered trials from official public datasets.Report a data error.